PhaseBio Pharmaceuticals, Inc. (PHAS) News PHAS Home News Ratings Charts PhaseBio Pharmaceuticals, Inc. (PHAS): $0.07 0.02 (-26.21%) POWR Rating Get Rating Component Grades Growth Get Rating Value Get Rating Momentum D Stability D Sentiment Get Rating Quality D Add PHAS to Watchlist Sign Up Industry: Medical - Pharmaceuticals Industry NR Ranked #119 of 164 in industry See All 'A' Rated Buy Stocks Filter PHAS News Items All News Types Featured Stories Commentary Search PHAS News Results Date Symbol Company Title Start End Change POWR Rating Loading, please wait... Load More News Items Most Popular Stories View All • Will Stocks Continue to Rise...Or Time for Rug Pull? • 4 Software Stocks Primed for Major Upside in 2024 • 3 Pharma Stocks Primed for May Investment Opportunities • 3 Bargain Internet Stock Buys for Savvy Investors • 2 Paths for Stocks from Here View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe
